Confo Therapeutics locks in $33.4 mln Series A

Confo Therapeutics, an emerging drug discovery company, has raised $33.4 million in Series A financing. The investors included BioGeneration Ventures, Wellington Partners, Fund+, Perceptive Advisors, Capricorn Health-Tech Fund, Qbic, Participatie Maatschappij Vlaanderen NV and V-Bio Ventures.

Source: Press Release